OREX Stock Ownership Activity

OREXIGEN THERAPEUTICS, INC COM 13F holders

No value investing guru has made any change to the OREXIGEN THERAPEUTICS, INC COM (OREX) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying OREX now?

According to the latest SEC filing(s) OREXIGEN THERAPEUTICS, INC COM (OREX) has not been purchased by any super investor.

To see more about who is investing in OREXIGEN THERAPEUTICS, INC COM (OREX), please go to the OREX ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2016 Q3 (1 result)
Seth Klarman
Baupost Group
-100.00%
-22,268,399
-0.14%
0.00%
Reported price*: $0.43
2016 Q1 (1 result)
Seth Klarman
Baupost Group
+881.68%
+20,000,000
+0.16%
0.18%
Reported price*: $0.56
2015 Q4 (1 result)
Seth Klarman
Baupost Group
+176.17%
+1,447,036
+0.05%
0.07%
Reported price*: $1.72
2015 Q3 (1 result)
Seth Klarman
Baupost Group
buy
+821,363
+0.03%
0.03%
Reported price*: $1.86
4 of 4

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.